ArticleScientific reports2025
MicroRNA expression in peripheral blood of children with asthma and the role of miR-31-5p in childhood asthma progression.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
MicroRNAs (miRNAs) have emerged as critical epigenetic regulators in the pathogenesis of childhood bronchial asthma. This study employed high-throughput sequencing to explore miRNA expression profiles in an asthma cohort, with a focus on elucidating the functional mechanisms of key miRNAs. Notably, among the miRNAs validated by RT-qPCR, miR-31-5p exhibited the largest area under the curve (AUC) value and demonstrated significant anti-inflammatory effects in an OVA-induced allergic inflammation mouse model. Bioinformatics analysis and dual-luciferase reporter assays confirmed that TBXA2R is a direct target of miR-31-5p. Mechanistically, stimulation with house dust mite (HDM) and IL-4 downregulated miR-31-5p expression in A549 cells, accompanied by elevated levels of TBXA2R and eotaxins (CCL11, CCL24, CCL26). Conversely, overexpression of miR-31-5p suppressed TBXA2R-mediated eotaxin production. These findings highlight the significant role of miR-31-5p in peripheral blood mononuclear cells (PBMCs) of asthmatic children, suggesting its potential involvement in upregulating eotaxin expression in A549 cells through negative regulation of TBXA2R.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.